Active Biotech Year-end report January
Active Biotech Year-end report January - December 2020 Fourth quarter in brief Tasquinimod The clinical study in multiple myeloma was presented at an oral poster session at the virtual American Society of Hematology (ASH) 2020 meeting in December Patent granted in China in October regarding treatment of multiple myeloma Patent granted in Europe in November regarding use of tasquinimod in combination with immunotherapy Laquinimod Naptumomab Corporate A Capital Markets Day was held on November...
United States Hans Kolam American Society Of Hematology European Hematology Association American Society Capital Markets Day
Source: finanznachrichten.de